Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Sipuleucel-T and Ipilimumab in Combination for Advanced Prostate Cancer

NCT01832870 is registered in ClinicalTrials.gov with Prostate Oncology Specialists, Inc. as lead sponsor.

NCT NCT01832870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01832870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Sipuleucel-T and Ipilimumab in Combination for Advanced Prostate Cancer
Lead sponsor
Prostate Oncology Specialists, Inc.
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2013
Completion date
February 29, 2016
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castrate resistant prostate cancer, prostate cancer